EDSA
Edesa Biotech Inc
3.90$
-3.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 23.01 | 7.69 | 2.74 | 4.44 | 2.06 | 4.00 | 6.05 | 9.59 | 0.46 | 0.63 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | 10.39 | 11.13 | 4.19 | 4.69 | 4.21 | 4.44 | 5.37 | 22.45 | 0.96 | 0.15 | 0.01 | 0.07 | 0.06 | 0.06 | 0.06 | 0.02 | |
| – | 12.62 | -3.44 | -1.44 | -0.25 | -2.15 | -0.43 | 0.68 | -12.86 | -0.50 | 0.47 | 0.25 | -0.07 | -0.06 | -0.06 | -0.06 | -0.02 | |
| – | 9.50 | 10.00 | 17.52 | 11.76 | 13.62 | 5.43 | 8.23 | 82.88 | 4.51 | 1.67 | 2.71 | 10.40 | 6.36 | 1.68 | 0.90 | 0.65 | |
| 8.15 | 30.99 | 64.35 | 42.55 | 18.26 | 15.90 | 17.04 | 15.81 | 123.69 | 5.96 | 3.12 | 2.75 | 3.32 | 2.40 | 1.55 | 1.29 | 0.75 | |
| 8.15 | 41.30 | 75.31 | 61.14 | 29.68 | 29.52 | 22.47 | 24.04 | 206.57 | 10.47 | 4.79 | 5.46 | 13.73 | 8.76 | 3.23 | 2.19 | 1.37 | |
| -8.15 | -28.68 | -78.29 | -62.58 | -29.93 | -31.67 | -22.90 | -23.36 | -219.43 | -10.97 | -4.32 | -5.21 | -13.73 | -8.76 | -3.23 | -2.19 | -1.39 | |
| 0.01 | 0.10 | 0.12 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.08 | 0.07 | 0.39 | – | – | – | |
| -7.67 | -15.84 | -78.13 | -49.85 | -121.14 | -46.60 | -14.81 | -23.88 | -211.25 | -10.89 | -4.24 | -5.18 | -7.73 | -8.37 | -2.93 | -1.93 | -1.27 | |
| – | 0.04 | 0.01 | 0.01 | 0.01 | 0.15 | 0.19 | 0.03 | 0.03 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -7.67 | -15.88 | -78.14 | -49.86 | -121.14 | -46.75 | -15.01 | -23.92 | -211.28 | -10.89 | -4.15 | -5.18 | -7.73 | -8.37 | -2.93 | -1.93 | -1.27 | |
| -6.71 | -20.51 | -38.70 | -61.73 | -30.30 | -45.72 | -13.97 | -23.17 | -203.72 | -10.48 | -4.31 | -5.16 | -7.66 | -8.33 | -3.23 | -1.92 | -1.24 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.